Sign in

Max Konig

@maxkonigmd.bsky.social
359 followers 142 following 12 posts

Rheumatologist/ Assistant Prof at Johns Hopkins | Director, Cellular Therapy Program (Autoimmunity) | Advancing precision immunotherapies for autoimmune diseases (www.koniglab.org). 🇩🇪🇺🇸

PostsRepliesMedia
Reposted by Max Konig
Waggoner Lab @labwaggoner.bsky.social · 21/10/2025
@biorxivpreprint.bsky.social Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells www.biorxiv.org/content/10.1... Great work @maxkonigmd.bsky.social
0134
Reposted by Max Konig
Bruce Levine, Ph.D. 🇺🇦 @bllphd.bsky.social · 23/03/2025
Your Orwellian Government at work - National Cancer Institute Employees Can’t Publish Information on These Topics Without Special Approval #NIH www.propublica.org/article/nati...
033
Reposted by Max Konig
RheumMadness @rheummadness.bsky.social · 09/01/2025
The #RheumMadness podcast is back! Join us as we discuss the T'd Up T-Cells Region, including: -BiTEs with @maxkonigmd.bsky.social -CD40L inhibitor for #Sjogren's with Duke rheum -Abatacept for pre-RA with Allegheny rheum rheummadness.buzzsprout.com/1465681/epis...
rheummadness.buzzsprout.com
5.2 T'd Up T-Cells - RheumMadness Podcast
In this episode, we dive in to the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational.  This is the first of a two-part conversation with the authors of the scouting reports ...
142
Reposted by Max Konig
Miguel Perales MD @drmiguelperales.bsky.social · 18/11/2024
Findings highlight ‘critical importance’ of infectious complications after CAR-T - read HemeOncToday interview with Kai Rejeski and me #medsky #CARTcells www.healio.com/news/hematol...
healio.com
Findings highlight ‘critical importance’ of infectious complications after CAR-T
Infections are the primary cause of nonrelapse mortality among individuals who undergo chimeric antigen receptor T-cell therapy, according to study results.Unique CAR-T-specific side effects — s...
0336
Max Konig @maxkonigmd.bsky.social · 17/11/2024
Targeting autoreactive TRBV9+ T cells using TRBV9xCD3 bispecific T cell engaging antibodies. Controlling ankylosing spondylitis and celiac disease without increasing the risk of infection? Let's go. Join us at Room 150, 3:00 PM. #precisionimmunotherapy #ACR24
1236
Max Konig @maxkonigmd.bsky.social · 17/11/2024
#ACR24 with emerging pathology superstar Jin Liu. APS session done. More on BaiTEs to come.
0111
Max Konig @maxkonigmd.bsky.social · 17/11/2024
While at it, if you are interested in learning more about off-the-shelf precision immunotherapies for the treatment of lupus, please join our talk on 9G4xCD3 T cell-engaging antibodies during the SLE - Cellular Therapy Session at 3 PM. #ACR24
1163
Max Konig @maxkonigmd.bsky.social · 17/11/2024
Congrats to Jin Liu for being awarded the ACR Emerging Investigator Excellence Award for her work on 9G4-targeted CAR/cTCR-T cells for the treatment of lupus. Join her talk today in the SLE - Cellular Therapy Session at 3 PM. #ACR24 #ProundMentorMoment
1122
Max Konig @maxkonigmd.bsky.social · 17/11/2024
Congrats to Steph Glavaris for being awarded the ACR Emerging Investigator Excellence Award for her work on T cell-engaging antibodies to deeply deplete TRBV9+, autoreactive T cells in ankylosing spondylitis and celiac disease. #ACR24 #ProundMentorMoment
153